PUBLICATIONS · 27908454
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet
- Publication date
- 2016 Dec 17
- First author
- Robertson JFR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet. 2017 Dec 17;388(10063):2961-2962. doi: 10.1016/S0140-6736(16)32418-7.
- note
- Source null
- related pmid
- 27908455
- relationship
- Comment in
Authors and identifiers
- name
- Robertson JFR
- type
- Author
- name
- Bondarenko IM
- type
- Author
- name
- Trishkina E
- type
- Author
- name
- Dvorkin M
- type
- Author
- name
- Panasci L
- type
- Author
- name
- Manikhas A
- type
- Author
- name
- Shparyk Y
- type
- Author
- name
- Cardona-Huerta S
- type
- Author
- name
- Cheung KL
- type
- Author
- name
- Philco-Salas MJ
- type
- Author
- name
- Ruiz-Borrego M
- type
- Author
- name
- Shao Z
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Robertson JFR
- type
- Author
- name
- Bondarenko IM
- type
- Author
- name
- Trishkina E
- type
- Author
- name
- Dvorkin M
- type
- Author
- name
- Panasci L
- type
- Author
- name
- Manikhas A
- type
- Author
- name
- Shparyk Y
- type
- Author
- name
- Cardona-Huerta S
- type
- Author
- name
- Cheung KL
- type
- Author
- name
- Philco-Salas MJ
- type
- Author
- name
- Ruiz-Borrego M
- type
- Author
- name
- Shao Z
- type
- Author
- bibliography ids
- nci-bib-1a2947424daac7ef7a9d2e9c
- book metadata
- content sha256
- 9f3880641ccda74c3601e6ee7f66d831b57348fa698c18c604ea2a64cd432576
- document type
- citation
- dois
- 10.1016/S0140-6736(16)32389-3
- electronic publication date
- display
- 2016 Nov 29
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27908454
- immutable id
- pubmed:27908454@9f3880641ccda74c3601e6ee7f66d831b57348fa698c18c604ea2a64cd432576
- journal
- abbreviation
- Lancet
- issn electronic
- 1474-547X
- issn print
- 0140-6736
- issue
- 10063
- name
- Lancet (London, England)
- nlm unique id
- 2985213R
- pages
- 2997-3005
- volume
- 388
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet. 2017 Dec 17;388(10063):2961-2962. doi: 10.1016/S0140-6736(16)32418-7.
- note
- Source null
- related pmid
- 27908455
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 27908454
- provenance
- batch id
- 7a1288ac8bb5f9826304
- provider
- NCBI PubMed ESummary
- record sha256
- d256bd0f9c0f6a9f0ade9594eba9a0d0117bc65bee6ccf9129d8940bb54b6b01
- response sha256
- 0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
- retrieved at
- 2026-09-09T23:47:23.138359+00:00
- publication date
- display
- 2016 Dec 17
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Preserved source evidence · Not medical advice
Triangle